Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 147 Total
GGR - Gogoro Inc - Stock Price Chart
TickerGGR [NASD]
CompanyGogoro Inc
CountryTaiwan
IndustryAuto Manufacturers
Market Cap373.62MEPS (ttm)-0.21
P/E-EPS this Y3.11%
Forward P/E-EPS next Y32.82%
PEG-EPS past 5Y-
P/S1.10EPS next 5Y-
P/B1.62EPS Q/Q68.21%
Dividend-Sales Q/Q-12.11%
Insider Own32.68%Inst Own13.34%
Insider Trans0.00%Inst Trans6.62%
Short Float1.42%EarningsMay 09/b
Analyst Recom1.00Target Price3.85
Avg Volume224.48K52W Range1.21 - 3.55
Gogoro, Inc. engages in the provision of electric scooter and related hardware and battery swapping and energy services. It offers Gogoro S1, Gogoro SuperSport, 2 Series, Gogoro VIVA, and Gogoro VIVA MIX.The company was founded by Horace Luke and Matt Taylor and is headquartered in Taipei, Taiwan.
CAVA - Cava Group Inc - Stock Price Chart
TickerCAVA [NYSE]
CompanyCava Group Inc
CountryUSA
IndustryRestaurants
Market Cap10.05BEPS (ttm)0.25
P/E346.54EPS this Y56.07%
Forward P/E203.63EPS next Y32.10%
PEG10.80EPS past 5Y-
P/S12.81EPS next 5Y32.10%
P/B17.31EPS Q/Q730.85%
Dividend-Sales Q/Q27.54%
Insider Own20.66%Inst Own72.09%
Insider Trans-23.04%Inst Trans-
Short Float12.79%EarningsMay 28/a
Analyst Recom1.81Target Price70.74
Avg Volume2.53M52W Range29.05 - 86.25
Cava Group, Inc. is a holding company, which engages in the operation of restaurants. It operates through the following segments: CAVA, Zoes Kitchen, and Other. The CAVA segment represents the financial results of all CAVA restaurants. The Zoes Kitchen segment focuses on the financial results of all Zoes Kitchen locations. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xenohristos TheodorosDirectorMar 26 '24Sale68.2947,2393,225,851526,521Mar 28 04:01 PM
Artal International S.C.A.DirectorMar 21 '24Sale66.252,000,000132,500,00026,507,990Mar 25 04:15 PM
SHAICH RONALD MFormer 10% OwnerMar 04 '24Sale57.201,500,00085,800,0004,457,634Mar 06 04:00 PM
Xenohristos TheodorosDirectorFeb 29 '24Sale58.514,500263,2950Mar 04 04:01 PM
Artal International S.C.A.DirectorFeb 27 '24Sale53.603,500,000187,600,00028,507,990Feb 29 04:16 PM
DERM - Journey Medical Corp - Stock Price Chart
TickerDERM [NASD]
CompanyJourney Medical Corp
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap77.04MEPS (ttm)-0.31
P/E-EPS this Y-345.24%
Forward P/E-EPS next Y74.33%
PEG-EPS past 5Y-
P/S0.96EPS next 5Y-
P/B5.93EPS Q/Q7.15%
Dividend-Sales Q/Q6.69%
Insider Own52.40%Inst Own9.07%
Insider Trans0.62%Inst Trans6.27%
Short Float2.94%EarningsMay 13/a
Analyst Recom1.00Target Price8.25
Avg Volume135.45K52W Range1.11 - 8.11
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROSENWALD LINDSAY A MDDirectorMar 25 '24Buy3.0410,00030,400144,245Mar 27 07:00 AM
Smith Justin AdamDirectorMar 22 '24Buy3.4730,000104,100134,717Mar 25 04:02 PM
ROSENWALD LINDSAY A MDDirectorMar 22 '24Buy3.4020,00068,000134,245Mar 25 04:01 PM
Maraoui ClaudePresident & CEOMar 22 '24Buy3.4810,00034,7902,163,430Mar 25 04:03 PM
Benesch JosephInterim CFOFeb 22 '24Sale3.752,4509,18860,710Feb 23 05:54 PM
COMM - CommScope Holding Company Inc - Stock Price Chart
TickerCOMM [NASD, RUT]
CompanyCommScope Holding Company Inc
CountryUSA
IndustryCommunication Equipment
Market Cap265.35MEPS (ttm)-8.85
P/E-EPS this Y-111.83%
Forward P/E2.29EPS next Y822.02%
PEG-EPS past 5Y-
P/S0.05EPS next 5Y-
P/B-EPS Q/Q-3055.89%
Dividend-Sales Q/Q-41.62%
Insider Own2.51%Inst Own83.22%
Insider Trans4.20%Inst Trans-0.33%
Short Float6.79%EarningsMay 09/b
Analyst Recom3.33Target Price1.21
Avg Volume3.70M52W Range0.86 - 6.64
CommScope Holding Co., Inc. engages in the provision of infrastructure solutions for communications networks. It operates through the following segments: Broadband, Home, Outdoor Wireless Networks (OWN), and Venue and Campus Networks (VCN). The company was founded by Frank M. Drendel in 1976 and is headquartered in Claremont, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lorentzen Kyle DavidEVP & CFOMar 27 '24Buy1.2511,60014,500712,475Mar 29 03:06 PM
KRAUSE L WILLIAMDirectorMar 13 '24Buy1.6092,127147,154320,000Mar 14 04:58 PM
KRAUSE L WILLIAMDirectorMar 12 '24Buy1.5957,30090,952227,873Mar 14 04:58 PM
Watts Claudius E. IVDirectorMar 05 '24Buy1.0515,00015,769941,830Mar 07 04:17 PM
ter Linde KoenSVP & President, CCSDec 07 '23Buy1.8413,51324,857236,300Dec 08 05:44 PM
TERN - Terns Pharmaceuticals Inc - Stock Price Chart
TickerTERN [NASD, RUT]
CompanyTerns Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap436.59MEPS (ttm)-1.26
P/E-EPS this Y-4.01%
Forward P/E-EPS next Y-2.84%
PEG-EPS past 5Y-12.40%
P/S-EPS next 5Y-
P/B1.84EPS Q/Q2.53%
Dividend-Sales Q/Q-
Insider Own33.54%Inst Own70.67%
Insider Trans-1.90%Inst Trans32.53%
Short Float5.20%EarningsMay 13/b
Analyst Recom1.50Target Price14.21
Avg Volume942.76K52W Range3.26 - 13.03
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vivo Opportunity, LLC10% OwnerApr 03 '24Sale6.20138,066856,009268,573Apr 03 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 02 '24Sale6.65101,480674,842272,722Apr 03 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 01 '24Sale6.99181,1171,266,008275,772Apr 03 08:47 PM
QTTB - Q32 Bio Inc. - Stock Price Chart
TickerQTTB [NASD]
CompanyQ32 Bio Inc.
CountryUSA
IndustryBiotechnology
Market Cap334.32MEPS (ttm)-35.16
P/E-EPS this Y47.05%
Forward P/E-EPS next Y-16.99%
PEG-EPS past 5Y-0.07%
P/S288.21EPS next 5Y-9.40%
P/B1.24EPS Q/Q53.43%
Dividend-Sales Q/Q-100.00%
Insider Own67.86%Inst Own8.46%
Insider Trans-0.28%Inst Trans-18.57%
Short Float0.82%EarningsMay 09/b
Analyst Recom1.00Target Price49.67
Avg Volume33.90K52W Range8.24 - 32.88
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alloway PaulSee RemarksMar 25 '24Sale24.212686,4882,596Apr 23 05:03 PM
Michaud Charles JrSee RemarksMar 25 '24Sale24.20751,815927Apr 23 05:00 PM
TZIANABOS ARTHURDirectorJan 09 '24Sale0.5713,0377,445128,778Feb 15 04:33 PM
Alloway PaulSee RemarksJan 03 '24Sale0.577,2804,12028,036Jan 05 05:54 PM
Michaud Charles JrSee RemarksJan 03 '24Sale0.571,70897511,598Jan 05 05:49 PM
DQ - Daqo New Energy Corp ADR - Stock Price Chart
TickerDQ [NYSE]
CompanyDaqo New Energy Corp ADR
CountryChina
IndustrySolar
Market Cap1.40BEPS (ttm)2.14
P/E9.95EPS this Y-64.10%
Forward P/E4.80EPS next Y119.56%
PEG-EPS past 5Y56.44%
P/S0.70EPS next 5Y-
P/B0.30EPS Q/Q-93.34%
Dividend-Sales Q/Q-41.49%
Insider Own0.49%Inst Own50.26%
Insider Trans0.00%Inst Trans6.98%
Short Float3.50%EarningsApr 29/b
Analyst Recom2.86Target Price25.37
Avg Volume1.36M52W Range17.30 - 43.66
Daqo New Energy Corp. is a holding company, which engages in the provision of polysilicon products. It involves in the manufacture and sale of polysilicon to photovoltaic product manufactures, who further process the polysilicon into ingots, wafers, cells, and modules for solar power solutions. The company was founded by Guang Fu Xu on November 22, 2007 and is headquartered in Shanghai, China.
PROK - ProKidney Corp - Stock Price Chart
TickerPROK [NASD, RUT]
CompanyProKidney Corp
CountryUSA
IndustryBiotechnology
Market Cap253.12MEPS (ttm)-0.57
P/E-EPS this Y-50.30%
Forward P/E-EPS next Y28.78%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q0.83%
Dividend-Sales Q/Q-
Insider Own29.65%Inst Own51.33%
Insider Trans0.22%Inst Trans2.15%
Short Float21.99%EarningsMay 10/b
Analyst Recom1.67Target Price6.33
Avg Volume796.42K52W Range1.12 - 13.51
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Darin J.Chief Regulatory OfficerMay 20 '24Sale4.0817,23870,386137,956May 22 07:22 AM
Weber Darin J.SVP of Regulatory DevelopmentApr 22 '24Sale2.5116,43841,315155,194Apr 23 04:05 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 18 '24Sale2.548002,028171,632Apr 23 04:05 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 16 '24Sale2.5017,23843,095172,432Apr 17 06:57 PM
Weber Darin J.SVP of Regulatory DevelopmentApr 12 '24Sale1.7384,103145,498189,670Apr 16 04:54 PM
PALT - Paltalk Inc - Stock Price Chart
TickerPALT [NASD]
CompanyPaltalk Inc
CountryUSA
IndustrySoftware - Application
Market Cap33.84MEPS (ttm)-0.09
P/E-EPS this Y283.33%
Forward P/E14.68EPS next Y13.64%
PEG-EPS past 5Y27.18%
P/S3.07EPS next 5Y-
P/B1.72EPS Q/Q33.33%
Dividend-Sales Q/Q1.31%
Insider Own36.11%Inst Own8.94%
Insider Trans-2.73%Inst Trans34.31%
Short Float0.11%EarningsMay 09/b
Analyst Recom1.00Target Price4.50
Avg Volume72.62K52W Range1.53 - 5.19
Paltalk, Inc. engages in the development of communications software to enhance security and privacy solutions for multimedia communication and data transmission. Its solutions include blockchain strategy consulting, blockchain implementation, white label video solutions, and technology licensing. The firm's product portfolio includes Paltalk and Camfrog. The company was founded by Clifford Lerner and Darrell Lerner on July 19, 2005 and is headquartered in Jericho, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
J. Crew Delaware Trust B10% OwnerMar 14 '24Sale4.9515741,477,408Mar 18 05:08 PM
J. Crew Delaware Trust B10% OwnerMar 13 '24Sale4.9712,69763,1041,477,423Mar 13 07:34 PM
J. Crew Delaware Trust B10% OwnerMar 11 '24Sale4.952,10710,4301,490,120Mar 13 07:34 PM
J. Crew Delaware Trust B10% OwnerFeb 28 '24Sale4.965192,5741,492,227Mar 01 04:05 PM
J. Crew Delaware Trust B10% OwnerFeb 26 '24Sale4.968944,4341,492,746Feb 28 04:05 PM
LANV - Lanvin Group Holdings Limited - Stock Price Chart
TickerLANV [NYSE]
CompanyLanvin Group Holdings Limited
CountryChina
IndustryLuxury Goods
Market Cap232.03MEPS (ttm)-1.32
P/E-EPS this Y6.43%
Forward P/E-EPS next Y2.63%
PEG-EPS past 5Y-
P/S0.50EPS next 5Y-
P/B0.77EPS Q/Q-3114.75%
Dividend-Sales Q/Q-
Insider Own9.70%Inst Own5.91%
Insider Trans0.00%Inst Trans0.30%
Short Float0.03%Earnings-
Analyst Recom3.00Target Price1.92
Avg Volume59.84K52W Range1.27 - 6.00
Lanvin Group Holdings Ltd. engages in the manufacturing and provision of leather goods, footwear, and accessories. The firm operates through the five portfolio brands: Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. The company was founded in 1889 and is headquartered in Shanghai, China.
156789101112131415